Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Innate Pharma S.A. ADR (IPHA)

Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Innate Pharma S.A. ADR 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 FRA

www.innate-pharma.com Employees: 181 P: 33-4-30-30-30-30 F: +33 430303000

Sector:

Medical

Description:

Innate Pharma S.A. is a commercial stage oncology-focused biotech company. It discovers and develops therapeutic antibodies for the treatment of cancer. The company's commercial-stage product includes Lumoxiti. Innate Pharma S.A. is based in Marseille, France.

Key Statistics

Overview:

Market Capitalization, $K 164,945
Enterprise Value, $K 126,635
Shares Outstanding, K 93,719
Float, K 63,832
% Float 68.11%
Short Interest, K 241
Short Float 0.26%
Days to Cover 15.02
Short Volume Ratio 0.38
% of Insider Shareholders 31.89%
% of Institutional Shareholders 0.16%

Financials:

Annual Sales, $ 21,770 K
Annual Net Income, $ -53,530 K
EBIT, $ 0 K
EBITDA, $ -53,650 K

Growth:

1-Year Return 4.37%
3-Year Return -50.70%
5-Year Return -60.80%
5-Year Revenue Growth -77.35%
5-Year Earnings Growth -94.12%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/26/26
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IPHA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -245.89%
Debt/Equity 5.25
Price/Sales 21.18
Price/Cash Flow N/A
Price/Book 27.68
Book Value/Share 0.06
Interest Coverage -11.45
60-Month Beta -0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar